Diaceutics

1. 06 Oct 26
   PDMR Shareholding/SIP and Total Voting Rights

   RNS 9807600 ↗
2. 24 Sep 26
   Diaceutics and Syndax expand Relay partnership

   Expanded partnership to support the commercialization of a diagnostic-driven therapy and help identify and treat eligible patients sooner

   RNS 9788006 ↗
3. 22 Sep 26
   Half-year Results

   Interim Results for the six months ended 30 June 2026

   RNS 9783201 ↗
4. 08 Sep 26
   Notice of Results & Presentations

   RNS 9759926 ↗
5. 02 Sep 26
   PDMR Shareholding/SIP & Total Voting Rights Director buys

   PDMR Shareholding/Share Incentive Plan and Total Voting Rights

   RNS 9752514 ↗
6. 20 Aug 26
   Diaceutics and PCC launch NGS Concordance Study

   Diaceutics and PCC launch NGS Concordance Study to advance precision oncology and support informed biomarker testing

   RNS 9731584 ↗
7. 04 Aug 26
   PDMR Shareholding/Share Incentive Plan & TVRs

   RNS 9704313 ↗
8. 29 Jul 26
   75% ARR Growth Drives Revenue & Profit Visibility

   Strong ARR growth of 75% drives H2 2026 revenue and profit visibility

   RNS 9692255 ↗
9. 03 Jul 26
   PDMR Shareholding/Share Incentive Plan and TVRs

   RNS 9650640 ↗
10. 25 Jun 26
    Result of AGM

    RNS 9637030 ↗
11. 01 Jun 26
    PDMR Shareholding/Share Incentive Plan & TVRs

    RNS 9595409 ↗
12. 29 May 26
    Notice of AGM & Posting of Annual Report

    RNS 9592654 ↗
13. 26 May 26
    Final Results

    Revenue growth of 24% on a constant currency basis to £38.4 million in FY 2025

    RNS 9583877 ↗
14. 13 May 26
    Notice of Results

    RNS 9565158 ↗
15. 12 May 26
    Holding(s) in Company

    RNS 9564585 ↗
16. 05 May 26
    PDMR Shareholding/Share Incentive Plan and TVRs

    RNS 9550749 ↗
17. 16 Apr 26
    Related Party Transaction - Lease Extension

    New York, Belfast and London, 16 April 2026 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, announces that it has agreed an extension to its existing property lease agreement for its Belfast...

    RNS 9524223 ↗
18. 07 Apr 26
    Block Listing Return

    RNS 9507160 ↗
19. 01 Apr 26
    PDMR Shareholding/SIP & Total Voting Rights

    RNS 9503656 ↗
20. 03 Mar 26
    PDMR Shareholding/Share Incentive Plan and TVRs

    RNS 9455906 ↗
21. 03 Feb 26
    PDMR Shareholding/Share Incentive Plan & TVR Director buys

    PDMR Shareholding/Share Incentive Plan and Total Voting Rights

    RNS 9404236 ↗
22. 15 Jan 26
    Full Year 2025 Trading Update

    Reported revenues expected to be £38.5 million, representing 20% growth and a return to profitability

    RNS 9354456 ↗
23. 23 Dec 25
    PDMR Shareholding/SIP & Total Voting Rights

    RNS 9314220 ↗
24. 28 Nov 25
    PDMR Shareholding/SIP & Total Voting Rights

    RNS 9263866 ↗
25. 04 Nov 25
    PDMR Shareholding/Share Incentive Plan and TVR

    RNS 9210114 ↗
26. 07 Oct 25
    Block listing Interim Review

    RNS 9154282 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.